The effectiveness of a standardized tobacco cessation program on psychophysiological parameters in patients with addiction undergoing long-term rehabilitation: a quasi-experimental pilot study.
Addiction therapy outcome
Heart rate variability
Self-efficacy
Tobacco cessation
Tobacco dependence
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
01 May 2024
01 May 2024
Historique:
received:
17
10
2023
accepted:
25
04
2024
medline:
2
5
2024
pubmed:
2
5
2024
entrez:
1
5
2024
Statut:
epublish
Résumé
Although there is a very high comorbidity between tobacco dependence and other addictive disorders, there are only few studies examining the implementation and outcomes of a tobacco cessation program in patients with addictive diseases. Therefore, the aim of this study is to investigate to what extent a standardized tobacco cessation program leads to improvements regarding psychological/physical parameters in patients with addiction undergoing therapy and whether there is a reduction in tobacco consumption. The study took place in a therapeutic community specialized in addiction therapy. A total sample of 56 participants were non-randomly assigned to an intervention group (IG; n = 31) and a treatment as usual group (TAUG; n = 25). The IG participated in a 6-week tobacco cessation program, while the TAUG received no additional treatment. Both groups were assessed for changes in primary outcomes (tobacco dependence, smoked cigarettes per day (CPD), and general substance-related craving) and secondary outcomes (heart rate variability (HRV): root mean square of successive differences, self-efficacy, and comorbid psychiatric symptoms) at two measurement time points (pre- and post-treatment/6 weeks). We observed significant improvements in self-efficacy (F The results highlight the potential benefit of an additional tobacco cessation program as part of a general addiction treatment. Although no improvements in the physiological domain were observed, there were significant improvements regarding self-efficacy and CPD in the IG compared to the TAUG. Randomized controlled trials on larger samples would be an important next step. ISRCTN15684371.
Sections du résumé
BACKGROUND
BACKGROUND
Although there is a very high comorbidity between tobacco dependence and other addictive disorders, there are only few studies examining the implementation and outcomes of a tobacco cessation program in patients with addictive diseases. Therefore, the aim of this study is to investigate to what extent a standardized tobacco cessation program leads to improvements regarding psychological/physical parameters in patients with addiction undergoing therapy and whether there is a reduction in tobacco consumption.
METHODS
METHODS
The study took place in a therapeutic community specialized in addiction therapy. A total sample of 56 participants were non-randomly assigned to an intervention group (IG; n = 31) and a treatment as usual group (TAUG; n = 25). The IG participated in a 6-week tobacco cessation program, while the TAUG received no additional treatment. Both groups were assessed for changes in primary outcomes (tobacco dependence, smoked cigarettes per day (CPD), and general substance-related craving) and secondary outcomes (heart rate variability (HRV): root mean square of successive differences, self-efficacy, and comorbid psychiatric symptoms) at two measurement time points (pre- and post-treatment/6 weeks).
RESULTS
RESULTS
We observed significant improvements in self-efficacy (F
CONCLUSIONS
CONCLUSIONS
The results highlight the potential benefit of an additional tobacco cessation program as part of a general addiction treatment. Although no improvements in the physiological domain were observed, there were significant improvements regarding self-efficacy and CPD in the IG compared to the TAUG. Randomized controlled trials on larger samples would be an important next step.
TRIAL REGISTRATION
BACKGROUND
ISRCTN15684371.
Identifiants
pubmed: 38693570
doi: 10.1186/s12916-024-03405-z
pii: 10.1186/s12916-024-03405-z
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
184Informations de copyright
© 2024. The Author(s).
Références
Preston SH, Glei DA, Wilmoth JR. A new method for estimating smoking-attributable mortality in high-income countries. Int J Epidemiol. 2010;39(2):430–8.
pubmed: 20032265
doi: 10.1093/ije/dyp360
Anzenberger J, Busch M, Klein C, Priebe B, Schmutterer I, Strizek J. Epidemiologiebericht Sucht 2022. Illegale Drogen, Alkohol und Tabak. Wien: Gesundheit Österreich; 2022.
Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res. 2011;13(6):401–11.
pubmed: 21464202
pmcid: 3103720
doi: 10.1093/ntr/ntr048
Parker MA, Sigmon SC, Villanti AC. Higher smoking prevalence among United States adults with co-occurring affective and drug use diagnoses. Addict Behav. 2019;99:106112.
pubmed: 31476691
pmcid: 6791776
doi: 10.1016/j.addbeh.2019.106112
Farrell M, Howes S, Bebbington P, Brugha T, Jenkins R, Lewis G, Marsden J, Taylor C, Meltzer H. Nicotine, alcohol and drug dependence, and psychiatric comorbidity–results of a national household survey. Int Rev Psychiatry. 2003;15(1–2):50–6.
pubmed: 12745310
doi: 10.1080/0954026021000045949
Balbuena L, Peters E, Speed D. Using polygenic risk scores to investigate the evolution of smoking and mental health outcomes in UK biobank participants. Acta Psychiatr Scand. 2023;148(5):447–56.
pubmed: 37607129
doi: 10.1111/acps.13601
Mühlig S. Tabakentwöhnung bei Patienten mit psychiatrischer Störung. Suchttherapie. 2009;10(01):914.
McKelvey K, Thrul J, Ramo D. Impact of quitting smoking and smoking cessation treatment on substance use outcomes: an updated and narrative review. Addict Behav. 2017;65:161–70.
pubmed: 27816663
doi: 10.1016/j.addbeh.2016.10.012
Prochaska JJ, Hall SM, Tsoh JY, Eisendrath S, Rossi JS, Redding CA, Rosen AB, Meisner M, Humfleet GL, Gorecki JA. Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning. Am J Public Health. 2008;98(3):446–8.
pubmed: 17600251
pmcid: 2253568
doi: 10.2105/AJPH.2006.101147
Stage KB, Glassman AH, Covey LS. Depression after smoking cessation. J Clin Psychiatry. 1996;57(10):467–9.
pubmed: 8909333
doi: 10.4088/JCP.v57n1005
Caldwell PE, Cutter HS. Alcoholics Anonymous affiliation during early recovery. J Subst Abuse Treat. 1998;15(3):221–8.
pubmed: 9633034
doi: 10.1016/S0740-5472(97)00191-8
Laudet AB, Morgen K, White WL. The role of social supports, spirituality, religiousness, life meaning and affiliation with 12-step fellowships in quality of life satisfaction among individuals in recovery from alcohol and drug problems. Alcohol Treat Q. 2006;24(1–2):33–73.
pubmed: 16892161
pmcid: 1526775
doi: 10.1300/J020v24n01_04
Cookson C, Strang J, Ratschen E, Sutherland G, Finch E, McNeill A. Smoking and its treatment in addiction services: clients’ and staff behaviour and attitudes. BMC Health Serv Res. 2014;14:1–8.
doi: 10.1186/1472-6963-14-304
Ziedonis DM, Guydish J, Williams J, Steinberg M, Foulds J. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2006;29(3):228.
pubmed: 17373414
pmcid: 6527042
Fu SS, Kodl M, Willenbring M, Nelson DB, Nugent S, Gravely AA, Joseph AM. Ethnic differences in alcohol treatment outcomes and the effect of concurrent smoking cessation treatment. Drug Alcohol Depend. 2008;92(1–3):61–8.
pubmed: 17689205
doi: 10.1016/j.drugalcdep.2007.06.014
Gwaltney CJ, Metrik J, Kahler CW, Shiffman S. Self-efficacy and smoking cessation: a meta-analysis. Psychol Addict Behav. 2009;23(1):56.
pubmed: 19290690
doi: 10.1037/a0013529
De Leon G, Unterrainer HF. The therapeutic community: A unique social psychological approach to the treatment of addictions and related disorders. Front Psychiatry. 2020;11:494340.
Chun J, Haug NA, Guydish JR, Sorensen JL, Delucchi K. Cigarette smoking among opioid-dependent clients in a therapeutic community. Am J Addict. 2009;18(4):316–20.
pubmed: 19444736
pmcid: 2756535
doi: 10.1080/10550490902925490
Moon SJE, Schlenk EA, Lee H. Heart rate variability in adults with substance use disorder: a comprehensive narrative review. J Am Psychiatr Nurses Assoc. (2024;30(2):240–51.
Cheng Y-C, Huang Y-C, Huang W-L. Heart rate variability as a potential biomarker for alcohol use disorders: a systematic review and meta-analysis. Drug Alcohol Depend. 2019;204:107502.
pubmed: 31494439
doi: 10.1016/j.drugalcdep.2019.05.030
Dinas PC, Koutedakis Y, Flouris AD. Effects of active and passive tobacco cigarette smoking on heart rate variability. Int J Cardiol. 2013;163(2):109–15.
pubmed: 22100604
doi: 10.1016/j.ijcard.2011.10.140
van Ravenswaaij-Arts CM, Kollee LA, Hopman JC, Stoelinga GB, van Geijn HP. Heart rate variability. Ann Intern Med. 1993;118(6):436–47.
pubmed: 8439119
doi: 10.7326/0003-4819-118-6-199303150-00008
Mather M, Thayer JF. How heart rate variability affects emotion regulation brain networks. Curr Opin Behav Sci. 2018;19:98–104.
pubmed: 29333483
pmcid: 5761738
doi: 10.1016/j.cobeha.2017.12.017
Rajendra Acharya U, Paul Joseph K, Kannathal N, Lim CM, Suri JS. Heart rate variability: a review. Med Biol Eng Comput. 2006;44:1031–51.
pubmed: 17111118
doi: 10.1007/s11517-006-0119-0
Harte CB, Meston CM. Effects of smoking cessation on heart rate variability among long-term male smokers. Int J Behav Med. 2014;21:302–9.
pubmed: 23397454
doi: 10.1007/s12529-013-9295-0
Stein PK, Rottman JN, Kleiger RE. Effect of 21 mg transdermal nicotine patches and smoking cessation on heart rate variability. Am J Cardiol. 1996;77(9):701–5.
pubmed: 8651120
doi: 10.1016/S0002-9149(97)89203-X
Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension. 1999;33(1):586–90.
pubmed: 9931170
doi: 10.1161/01.HYP.33.1.586
Yotsukura M, Koide Y, Fujii K, Tomono Y, Katayama A, Ando H, Suzuki J, Ishikawa K. Heart rate variability during the first month of smoking cessation. Am Heart J. 1998;135(6):1004–9.
pubmed: 9630104
doi: 10.1016/S0002-8703(98)70065-1
Dilling H, Mombour W, Schmidt M.H. Internationale Klassifikation psychischer Störungen ICD-10, Kapitel V (F): Klinisch-diagnostische Leitlinien [International Classification of Diseases ICD-10]. Bern: Verlag Hans Huber; 2005.
Batra A, Buchkremer G. Nichtrauchen!: Erfolgreich aussteigen in sechs Schritten. Stuttgart: Stuttgart Kohlhammer Verlag; 2017.
Rauchfreiapp [ https://rauchfreiapp.at/ ].
Rauchfrei Telefon [ https://rauchfrei.at/ ].
Derogatis LR. Brief symptom inventory 18. Baltimore: Johns Hopkins University Baltimore; 2001.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.
pubmed: 1932883
doi: 10.1111/j.1360-0443.1991.tb01879.x
Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence. Nicotine Tob Res. 2011;14(1):75–8.
pubmed: 22025545
doi: 10.1093/ntr/ntr137
Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF. Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom test for nicotine dependence. Addict Behav. 1994;19(1):33–9.
pubmed: 8197891
doi: 10.1016/0306-4603(94)90049-3
Nakovics H, Diehl A, Geiselhart H, Mann K. Development and validation of an overall instrument to measure craving across multiple substances: the Mannheimer Craving Scale (MaCS). Psychiatr Prax. 2008;36(2):72–8.
pubmed: 18924060
doi: 10.1055/s-2008-1067546
Schwarzer R, Jerusalem M. Skalen zur Erfassung von Lehrer- und Schülermerkmalen. Dokumentation der psychometrischen Verfahren im Rahmen der Wissenschaftlichen Begleitung des Modellversuchs Selbstwirksame Schulen. Berlin: Freie Universität Berlin; 1999.
Tarvainen MP, Lipponen J, Niskanen JP, Ranta-aho PO. Kubios HRV software user’s guide version 3.5. Kubios Oy. 2021..
Sztajzel J. Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly. 2004;134(3536):514–22.
pubmed: 15517504
Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017;5:290215.
doi: 10.3389/fpubh.2017.00258
Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10(1):88–101.
pubmed: 15649244
pmcid: 6932537
doi: 10.1111/j.1542-474X.2005.10101.x
Munoz ML, Van Roon A, Riese H, Thio C, Oostenbroek E, Westrik I, de Geus EJ, Gansevoort R, Lefrandt J, Nolte IM. Validity of (ultra-) short recordings for heart rate variability measurements. PLoS One. 2015;10(9):e0138921.
pubmed: 26414314
pmcid: 4586373
doi: 10.1371/journal.pone.0138921
Parsons N. Repolr: An R package for fitting proportional-odds models to repeated ordinal scores, 2017. Avalible from: https://CRAN.R-project.org/package=repolr .
Munafò MR, Nosek BA, Bishop DV, Button KS, Chambers CD. Percie du Sert N, Simonsohn U, Wagenmakers E-J, Ware JJ, Ioannidis J: A manifesto for reproducible science. Nat Hum Behav. 2017;1(1):1–9.
doi: 10.1038/s41562-016-0021
Richter KP, McCool RM, Okuyemi KS, Mayo MS, Ahluwalia JS. Patients’ views on smoking cessation and tobacco harm reduction during drug treatment. Nicotine Tob Res. 2002;4(Suppl_2):S175–82.
pubmed: 12573178
doi: 10.1080/1462220021000032735
Black N, Eisma MC, Viechtbauer W, Johnston M, West R, Hartmann-Boyce J, Michie S, de Bruin M. Variability and effectiveness of comparator group interventions in smoking cessation trials: a systematic review and meta-analysis. Addiction. 2020;115(9):1607–17.
pubmed: 32043675
pmcid: 7496125
doi: 10.1111/add.14969
Smith PH, Bessette AJ, Weinberger AH, Sheffer CE, McKee SA. Sex/gender differences in smoking cessation: a review. Prev Med. 2016;92:135–40.
pubmed: 27471021
pmcid: 5085924
doi: 10.1016/j.ypmed.2016.07.013
Malivert M, Fatséas M, Denis C, Langlois E, Auriacombe M. Effectiveness of therapeutic communities: a systematic review. Eur Addict Res. 2011;18(1):1–11.
pubmed: 21997500
doi: 10.1159/000331007
Vanderplasschen W, Colpaert K, Autrique M, Rapp RC, Pearce S, Broekaert E, Vandevelde S. Therapeutic communities for addictions: a review of their effectiveness from a recovery-oriented perspective. ScientificWorldJournal. 2013;2013:427817.
pubmed: 23401669
pmcid: 3562581
doi: 10.1155/2013/427817